Encompass Health (EHC)
(Delayed Data from NYSE)
$82.80 USD
+0.34 (0.41%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $82.83 +0.03 (0.04%) 7:58 PM ET
2-Buy of 5 2
A Value C Growth D Momentum B VGM
Income Statements
Fiscal Year end for Encompass Health Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 4,801 | 4,349 | 5,122 | 4,644 | 4,605 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 4,801 | 4,349 | 5,122 | 4,644 | 4,605 |
Selling & Adminstrative & Depr. & Amort Expenses | 4,069 | 3,720 | 4,316 | 4,002 | 3,920 |
Income After Depreciation & Amortization | 732 | 629 | 806 | 643 | 685 |
Non-Operating Income | 19 | -2 | 16 | 14 | 37 |
Interest Expense | 144 | 176 | 165 | 184 | 160 |
Pretax Income | 607 | 451 | 657 | 473 | 562 |
Income Taxes | 132 | 100 | 140 | 104 | 116 |
Minority Interest | 111 | 95 | 105 | 85 | 87 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 475 | 351 | 518 | 369 | 446 |
Extras & Discontinued Operations | -12 | 15 | 0 | 0 | -1 |
Net Income (GAAP) | 352 | 271 | 412 | 284 | 359 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,015 | 882 | 1,070 | 893 | 908 |
Depreciation & Amortization (Cash Flow) | 283 | 253 | 264 | 250 | 223 |
Income After Depreciation & Amortization | 732 | 629 | 806 | 643 | 685 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 101.30 | 100.40 | 100.20 | 99.80 | 99.40 |
Diluted EPS Before Non-Recurring Items | 3.64 | 2.85 | 4.23 | 2.89 | 3.91 |
Diluted Net EPS (GAAP) | 3.47 | 2.70 | 4.11 | 2.85 | 3.61 |
Fiscal Year end for Encompass Health Corporation falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 1,246.80 | 1,206.90 | 1,187.10 | 1,160.40 |
Cost Of Goods | NA | -177.90 | 0.00 | 0.00 | 177.90 |
Gross Profit | NA | 1,246.80 | 1,206.90 | 1,187.10 | 982.50 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 1,234.80 | 1,027.50 | 1,003.20 | 803.90 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 12.00 | 179.40 | 183.90 | 178.60 |
Non-Operating Income | NA | 9.80 | 1.50 | 3.60 | 4.00 |
Interest Expense | NA | 34.90 | 35.90 | 36.30 | 36.40 |
Pretax Income | NA | 164.80 | 145.00 | 151.20 | 146.20 |
Income Taxes | NA | 37.20 | 30.30 | 32.80 | 31.90 |
Minority Interest | NA | 31.50 | 28.10 | 25.80 | 25.60 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 127.60 | 114.70 | 118.40 | 114.30 |
Extras & Discontinued Operations | NA | -8.50 | -1.30 | -1.20 | -1.00 |
Net Income (GAAP) | NA | 87.60 | 85.30 | 91.40 | 87.70 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 101.50 | 101.40 | 101.10 | 100.90 |
Diluted EPS Before Non-Recurring Items | NA | 0.95 | 0.86 | 0.95 | 0.88 |
Diluted Net EPS (GAAP) | NA | 0.86 | 0.84 | 0.90 | 0.87 |